• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BDX
Click for more information
1.08% 9.4¢

BCAL DIAGNOSTICS LIMITED - Corporate Spotlight

Market Cap $23.71M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

BCAL Diagnostics Limited is an Australia-based biotechnology company, which is focused on... BCAL Diagnostics Limited is an Australia-based biotechnology company, which is focused on improving health outcomes for women. The Company’s principal activities include the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, including preparation for clinical trials. It developed a blood screening test to be used alongside breast cancer screening methods. The technology initially complements imaging technologies, such as the mammogram, while it further progresses the development of a monitoring and screening test suitable for women of all ages and backgrounds in any location. Its BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring. The Company has partnered with Precion Inc. to optimize protocols and procedures for the clinical studies required for regulatory approvals across several jurisdictions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
9.4¢ 		Change
0.001(1.08%) 		Mkt cap ! $23.71M
Open High Low Value Volume
9.3¢ 9.9¢ 9.3¢ $4.177K 43.04K

Buyers (Bids)

No. Vol. Price($)
1 172 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 95238 1
View Market Depth
Last trade - 12.45pm 10/05/2024 (20 minute delay) ?
Last
9.8¢ 		  Change
0.001 ( 6.52 %)
Open High Low Volume
9.1¢ 9.8¢ 9.1¢ 36921
Last updated 11.55am 10/05/2024 ?
BDX (ASX) Chart

Top Stories

Maiden drilling at West Arunta hints at major IOCG system for Rincon

Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
CBA profits fall 3% in March quarter but funding portfolio is flourishing Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
Raiden opens door to private Mallina in win-win Arrow Gold divestment Raiden Resources has announced its execution of a farm-in deal on-site Raiden's non-core asset, the Arrow gold project.
Recce breathes better on positive lung infection drug pilot test results Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.